Aeluma is trading 6.09% up now at $13.50 as investors continue reacting to its September 16 fiscal 2026 results, including a CHIPS Act letter of intent for up to $30 million and expanded AI-datacom manufacturing plans.
- The company also announced a strategic Sumitomo Chemical agreement to increase wafer capacity.
- The broader risk-on backdrop is supportive, with major U.S. indexes higher in pre-market trading.
- The move follows elevated volatility, including a 10.22% gain on September 18.